Thomas Patrick Kelly

Insider Reports History

Location
Waltham, MA
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Patrick Kelly:

Company Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Chief Financial Officer Common Stock 0 $0 $15.62 11 Jun 2024 Direct
Deciphera Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 $0 $10.58 11 Jun 2024 Direct
Xenon Pharmaceuticals Inc. Chief Financial Officer Share Option (Right to Buy) 225,000 15 Oct 2025 Direct
Xenon Pharmaceuticals Inc. Chief Financial Officer Restricted Share Units 30,000 15 Oct 2025 Direct
Xenon Pharmaceuticals Inc. Chief Financial Officer No securities are beneficially owned. 0 15 Oct 2025 Direct

Insider Reports Filed by Thomas Patrick Kelly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 15 Oct 2025 2 $0 4 Chief Financial Officer 17 Oct 2025, 18:43
XENE Xenon Pharmaceuticals Inc. 15 Oct 2025 0 $0 3 Chief Financial Officer 17 Oct 2025, 18:41
/report/000095017024072221-kelly-thomas-patrick-2024-06-11 Deciphera Pharmaceuticals, Inc. 11 Jun 2024 10 $0 4 Chief Financial Officer 11 Jun 2024, 20:56
/report/000095017024017091-kelly-thomas-patrick-2024-02-15 Deciphera Pharmaceuticals, Inc. 15 Feb 2024 3 -$47,009 4 Chief Financial Officer 20 Feb 2024, 16:05
/report/000095017024005389-kelly-thomas-patrick-2024-01-16 Deciphera Pharmaceuticals, Inc. 16 Jan 2024 1 -$35,234 4 Chief Financial Officer 18 Jan 2024, 16:15
/report/000095017023070384-kelly-thomas-patrick-2023-12-12 Deciphera Pharmaceuticals, Inc. 12 Dec 2023 2 -$42,905 4 Chief Financial Officer 14 Dec 2023, 16:05
/report/000120919123053936-kelly-thomas-patrick-2023-10-28 Deciphera Pharmaceuticals, Inc. 28 Oct 2023 2 -$27,833 4 Chief Financial Officer 31 Oct 2023, 16:09
/report/000120919123038755-kelly-thomas-patrick-2023-06-16 Deciphera Pharmaceuticals, Inc. 16 Jun 2023 1 -$23,835 4 Chief Financial Officer 21 Jun 2023, 16:05
/report/000120919123010519-kelly-thomas-patrick-2023-02-15 Deciphera Pharmaceuticals, Inc. 15 Feb 2023 3 -$20,686 4 Chief Financial Officer 17 Feb 2023, 15:09
/report/000120919123003994-kelly-thomas-patrick-2023-01-17 Deciphera Pharmaceuticals, Inc. 17 Jan 2023 1 -$51,043 4 Chief Financial Officer 19 Jan 2023, 15:05
/report/000120919122038426-kelly-thomas-patrick-2022-06-16 Deciphera Pharmaceuticals, Inc. 16 Jun 2022 1 -$19,006 4 Chief Financial Officer 21 Jun 2022, 16:35
/report/000120919122011357-kelly-thomas-patrick-2022-02-16 Deciphera Pharmaceuticals, Inc. 16 Feb 2022 1 -$12,380 4 Chief Financial Officer 18 Feb 2022, 16:01
/report/000120919122004078-kelly-thomas-patrick-2022-01-18 Deciphera Pharmaceuticals, Inc. 18 Jan 2022 2 $0 4 Chief Financial Officer 20 Jan 2022, 16:00
/report/000120919121070250-kelly-thomas-patrick-2021-12-15 Deciphera Pharmaceuticals, Inc. 15 Dec 2021 2 $0 4 Chief Financial Officer 17 Dec 2021, 15:10